FIELD: medical devices.
SUBSTANCE: group of inventions relates to medicinal product delivery through expandable catheters. The following is presented: a catheter comprising an expandable part on an elongated body; and a coating on the outer surface of the expandable part. The said coating contains a lipophilic matrix with at least one lipid, more than one microreservoir, including only a crystalline active agent dispersed in the lipophilic matrix. The lipophilic matrix is configured to adhere to the intraluminal surface when the expandable portion is inflated and transfer at least a part from more than one microreservoir to the intraluminal surface. More than one microreservoir is uniform in size and has a maximum particle size of 10 μm, and less than 5% of the more than one microreservoir has a diameter of 1 μm or less. A method of coating an expandable part of a catheter and a method of treating a condition at a treatment site are also described.
EFFECT: maximum therapeutic effect is achieved with minimal toxicity of high doses of medicinal products.
45 cl, 8 dwg, 20 tbl, 14 ex
Title |
Year |
Author |
Number |
COATING FOR AN INTRALUMINAL DIVERGENT CATHETER, PROVIDING CONTACT DELIVERY OF MICRORESERVOIRS WITH A DRUG PREPARATION |
2015 |
- Eliker Robert Dzhon
- Alering Majkl Tomas
- Yamamoto Ronald Kenichi
- Ngujen Tien Tuj
- Shultse Dzhon Edvin
- Zutkhaut Jelle Yuren
|
RU2721655C2 |
OXIDISED LIPIDES AND USE THEREOF FOR TREATING INFLAMMATORY DISEASES AND DISORDERS |
2009 |
- Kharats Dror
- Dzhordzh Jakob
- Khal'Perin Gideon
- Jakov Niva
- Kovalevski-Ishai Ehti
|
RU2482854C2 |
PEGYLATED LIPID NANOPARTICLE WITH A BIOACTIVE LIPOPHILIC COMPOUND |
2016 |
- Gaillard, Pieter Jaap
- Rip, Jacob
|
RU2737893C2 |
OXIDISED LIPIDS AND THEIR APPLICATION FOR TREATMENT OF INFLAMMATORY DISEASES AND DISTURBANCES |
2004 |
- Kharats Dror
- Dzhordzh Jakob
- Khal'Perin Gideon
- Jakov Niva
- Kovalevski-Ishai Ehti
|
RU2362567C2 |
RESPIRATORY INTRODUCTION OF TISSUE FACTOR PATHWAY INHIBITOR IN INFLAMMATORY CONDITIONS INVOLVING RESPIRATORY TRACT |
2006 |
|
RU2496516C2 |
PEPTIDE POSSESSING ABILITY TO RELIEVE AT LEAST ONE SYMPTOM OF INFLAMMATORY CONDITION, PHARMACEUTICAL COMPOSITION CONTAINING IT AND METHOD OF TREATING ATHEROSCLEROSIS WITH THEIR APPLICATION |
2005 |
- Anantkharamajakh Gattadakhalli M.
- Navab Mokhamad
- Fogelmehn Ehlan M.
|
RU2448977C2 |
STABILIZED PHARMACEUTICAL COMPOSITIONS OF CAMPTOTHECIN |
2016 |
- Drummond, Daryl, C.
- Kirpotin, Dmitri, B.
- Hayes, Mark, Eamon
- Noble, Charles
- Kesper, Kevin
- Awad, Antoine, M.
- Moore, Douglas, J.
- O'Brien, Andrew, J.
|
RU2732567C2 |
OXIDISED LIPID COMPOUNDS AND THEIR APPLICATION |
2009 |
- Kovalevski-Ishai Ehti
- Zenjuk Zeev
- Khal'Perin Gideon
- Mendel' Itskhak
- Fajge Frez
- Jakov Niva
- Brajtbart Ehjal'
|
RU2532546C2 |
LIPID COMPOUND AND COMPOSITION BASED THEREON |
2021 |
- Zhang, Bill Biliang
- Zhao, Haoting
- Wen, Jian
|
RU2825571C1 |
RESPIRATORY INTRODUCTION OF ACTIVATED PROTEIN C IN INFLAMMATORY CONDITIONS INVOLVING RESPIRATORY TRACT |
2006 |
|
RU2496515C2 |